Sakar Healthcare Limited (NSE:SAKAR)
India
· Delayed Price · Currency is INR 527.95
-0.10 (-0.02%)
At close: Mar 6, 2026
Sakar Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 2,309 | 1,776 | 1,534 | 1,334 | 1,282 | 947.39 | Upgrade
|
| Other Revenue | 5.22 | 5.22 | 8.16 | 8.33 | 8.91 | 5.72 | Upgrade
|
| Revenue | 2,314 | 1,781 | 1,542 | 1,342 | 1,291 | 953.12 | Upgrade
|
| Revenue Growth (YoY) | 35.15% | 15.53% | 14.89% | 3.93% | 35.47% | 13.58% | Upgrade
|
| Cost of Revenue | 1,097 | 824.14 | 842.09 | 737.45 | 748.77 | 514.6 | Upgrade
|
| Gross Profit | 1,217 | 956.93 | 699.59 | 604.47 | 542.41 | 438.52 | Upgrade
|
| Selling, General & Admin | 417.51 | 317.32 | 198.62 | 169.35 | 153.55 | 132.82 | Upgrade
|
| Other Operating Expenses | 206.45 | 133.66 | 106.73 | 94.1 | 85.81 | 73.86 | Upgrade
|
| Operating Expenses | 855.01 | 659.8 | 485.85 | 413.3 | 336.04 | 287.26 | Upgrade
|
| Operating Income | 361.84 | 297.13 | 213.73 | 191.17 | 206.38 | 151.26 | Upgrade
|
| Interest Expense | -90 | -78.97 | -67.45 | -54.88 | -25.88 | -23.34 | Upgrade
|
| Interest & Investment Income | 0.18 | 0.18 | 1.25 | 3.93 | 0.56 | 0.16 | Upgrade
|
| Currency Exchange Gain (Loss) | 7.4 | 7.4 | 17.23 | 34.49 | 11.62 | 5.85 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.29 | -6.57 | -8.71 | -4.75 | -3.22 | -1.61 | Upgrade
|
| EBT Excluding Unusual Items | 282.71 | 219.18 | 156.06 | 169.96 | 189.46 | 132.33 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 2.94 | - | 0.62 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -3.39 | -3.39 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | -0.51 | - | -0.05 | - | - | Upgrade
|
| Pretax Income | 279.32 | 215.27 | 159 | 169.91 | 190.08 | 132.33 | Upgrade
|
| Income Tax Expense | 27.1 | 40.25 | 42.29 | 42.33 | 37.65 | 25.5 | Upgrade
|
| Net Income | 252.21 | 175.02 | 116.71 | 127.59 | 152.43 | 106.83 | Upgrade
|
| Net Income to Common | 252.21 | 175.02 | 116.71 | 127.59 | 152.43 | 106.83 | Upgrade
|
| Net Income Growth | 69.71% | 49.96% | -8.53% | -16.30% | 42.69% | 11.01% | Upgrade
|
| Shares Outstanding (Basic) | 22 | 22 | 21 | 19 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 22 | 22 | 21 | 19 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 2.26% | 6.20% | 11.49% | 23.33% | - | 0.77% | Upgrade
|
| EPS (Basic) | 11.38 | 7.97 | 5.64 | 6.86 | 10.11 | 7.09 | Upgrade
|
| EPS (Diluted) | 11.37 | 7.95 | 5.63 | 6.86 | 10.11 | 7.09 | Upgrade
|
| EPS Growth | 65.96% | 41.21% | -17.95% | -32.13% | 42.69% | 10.17% | Upgrade
|
| Free Cash Flow | - | 17.5 | -350.93 | -488.51 | -109.08 | -209.69 | Upgrade
|
| Free Cash Flow Per Share | - | 0.80 | -16.93 | -26.27 | -7.24 | -13.91 | Upgrade
|
| Gross Margin | 52.59% | 53.73% | 45.38% | 45.05% | 42.01% | 46.01% | Upgrade
|
| Operating Margin | 15.64% | 16.68% | 13.86% | 14.25% | 15.98% | 15.87% | Upgrade
|
| Profit Margin | 10.90% | 9.83% | 7.57% | 9.51% | 11.80% | 11.21% | Upgrade
|
| Free Cash Flow Margin | - | 0.98% | -22.76% | -36.40% | -8.45% | -22.00% | Upgrade
|
| EBITDA | 576.69 | 496.85 | 393.27 | 341.03 | 279.66 | 206.34 | Upgrade
|
| EBITDA Margin | 24.92% | 27.90% | 25.51% | 25.41% | 21.66% | 21.65% | Upgrade
|
| D&A For EBITDA | 214.86 | 199.72 | 179.54 | 149.86 | 73.28 | 55.08 | Upgrade
|
| EBIT | 361.84 | 297.13 | 213.73 | 191.17 | 206.38 | 151.26 | Upgrade
|
| EBIT Margin | 15.64% | 16.68% | 13.86% | 14.25% | 15.98% | 15.87% | Upgrade
|
| Effective Tax Rate | 9.70% | 18.70% | 26.60% | 24.91% | 19.81% | 19.27% | Upgrade
|
| Revenue as Reported | 2,332 | 1,789 | 1,565 | 1,380 | 1,304 | 959.15 | Upgrade
|
| Advertising Expenses | - | 0.07 | 0.07 | 0.28 | 0.22 | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.